tiprankstipranks
Haemonetics Corp. (HAE)
NYSE:HAE
Holding HAE?
Track your performance easily

Haemonetics (HAE) Financial Statements

391 Followers

Haemonetics Financial Overview

Haemonetics's market cap is currently ―. The company's EPS TTM is $2.407; its P/E ratio is 35.27; Haemonetics is scheduled to report earnings on February 11, 2025, and the estimated EPS forecast is $1.18. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 345.51M$ 336.17M$ 343.29M$ 336.25M$ 318.18M
Gross Profit$ 187.44M$ 174.92M$ 175.91M$ 177.87M$ 170.51M
EBIT$ 44.73M$ 46.67M$ 23.18M$ 45.98M$ 35.30M
EBITDA$ 77.69M$ 81.05M$ 54.95M$ 69.51M$ 58.32M
Net Income Common Stockholders$ 33.83M$ 50.88M$ 20.37M$ 31.24M$ 24.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 299.28M$ 344.43M$ 178.80M$ 193.98M$ 351.00M
Total Assets$ 2.53B$ 2.54B$ 2.20B$ 2.20B$ 2.01B
Total Debt$ 1.22B$ 1.22B$ 807.79M$ 870.59M$ 762.23M
Net Debt$ 925.67M$ 879.16M$ 628.99M$ 676.61M$ 411.22M
Total Liabilities$ 1.65B$ 1.64B$ 1.24B$ 1.26B$ 1.12B
Stockholders Equity$ 878.85M$ 905.37M$ 959.96M$ 943.32M$ 893.66M
Cash Flow-
Free Cash Flow$ 39.58M$ -12.71M$ 54.95M$ -22.83M$ 74.47M
Operating Cash Flow$ 48.82M$ -27.42M$ 64.08M$ -540.00K$ 99.12M
Investing Cash Flow$ -23.37M$ -139.20M$ -13.06M$ -268.94M$ -25.14M
Financing Cash Flow$ -74.80M$ 333.69M$ -63.50M$ 109.43M$ -7.17M
Currency in USD

Haemonetics Earnings and Revenue History

Haemonetics Debt to Assets

Haemonetics Cash Flow

Haemonetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis